Cannabinoid Pharmacology

Understanding how cannabinoids interact with the human body is fundamental to both medicine and product development. Cannabinoid Pharmacology covers the science of the endocannabinoid system, receptor binding profiles (CB1, CB2, GPR55, TRPV1), and the pharmacokinetics of major and minor cannabinoids including THC, CBD, CBG, CBN, THCV, and delta-8-THC. We report on the entourage effect, terpene-cannabinoid synergies, bioavailability of different delivery methods, and emerging research on novel synthetic cannabinoids.

This sub-category is essential reading for pharmacologists, formulation scientists, medical practitioners, and advanced consumers who want to understand the mechanisms behind therapeutic efficacy. From first-pass metabolism and cytochrome P450 drug interactions to the nuances of full-spectrum versus isolate formulations, our coverage bridges the gap between laboratory science and clinical application.